Keywords: hPFS; hepatic progression-free survival; TARE; transarterial radioembolization; UM; uveal melanoma; 90Y; yttrium-90;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AST; aspartate transaminase; CEA; carcinoembryonic antigen; CRC; colorectal cancer; NLR; neutrophil-lymphocyte ratio; OS; overall survival; RE; radioembolization; 90Y; yttrium-90;
Keywords: TARE; transarterial radioembolization; 90Y; yttrium-90;
Keywords: CI; confidence interval; FLR; future liver remnant; HCC; hepatocellular carcinoma; IQR; interquartile range; PVE; portal vein embolization; TLV; total liver volume; 90Y; yttrium-90;
Keywords: HCC; hepatocellular carcinoma; PVA; polyvinyl alcohol; RIPA; right inferior phrenic artery; 90Y; yttrium-90;
Keywords: CI; confidence interval; CRLM; colorectal cancer liver metastases; 18F-FDG; 18F-fluorodeoxyglucose; HR; hazard ratio; LTD; longest tumor diameter; NTL; nontarget lesion; OS; overall survival; PET; positron emission tomography; RE; radioembolization; RECIS
Keywords: CI; confidence interval; mRECIST; modified Response Evaluation Criteria in Solid Tumors; RCC; renal cell carcinoma; 90Y; yttrium-90;
Keywords: BCLC; Barcelona Clinic Liver Cancer; DEE; drug-eluting embolics; HCC; hepatocellular carcinoma; 90Y; yttrium-90;
Keywords: ANOVA; analysis of variance; DEE; drug-eluting embolic; HCC; hepatocellular carcinoma; ICC; intrahepatic cholangiocarcinoma; mCRC; metastatic colorectal carcinoma; SHAPD; systemic-hepatic artery pressure difference; SIS; Surefire Infusion System; TARE; tr
Keywords: CI; confidence interval; HCC; hepatocellular carcinoma; HR; hazard ratio; IPTW; inverse probability of treatment weight; IQR; interquartile range; OLT; orthotopic liver transplantation; OS; overall survival; PFS; progression-free survival; PS; propensity
Keywords: ALBI; albumin-bilirubin; BCLC; Barcelona Liver Clinic Cancer; CI; confidence interval; CPC; Child-Pugh class; HCC; hepatocellular carcinoma; N/A; not applicable; PALBI; platelet-bilirubin-albumin; 90Y; yttrium-90;
Keywords: Radioactive synoviorthesis; Pediatric; Adolescent; Hemophilia; 90Y; 186ReSinoviortesis radioisotópica; Pediátrico; Adolescente; Hemofilia; 90Y; 186Re
Keywords: Sinoviortesis radioisotópica; Pediátrico; Adolescente; Hemofilia; 90Y; 186ReRadioactive synoviorthesis; Paediatric; Adolescent; Haemophilia; 90Y; 186Re
Keywords: Ang-2; angiopoietin-2; HCC; hepatocellular carcinoma; IL; interleukin; OLT; orthotopic liver transplantation; PDGF; platelet-derived growth factor; VEGF; vascular endothelial growth factor; 90Y; yttrium-90;
Keywords: ALBI; albumin-bilirubin; BCLC; Barcelona Clinic Liver Cancer; C-P; Child-Pugh; CI; confidence interval; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; OS; median overall survival; 90Y; yttrium-90;
Keywords: AST; aspartate aminotransferase; BSA; body surface area; CI; confidence interval; CP; Child-Pugh; HCC; hepatocellular carcinoma; HR; hazard ratio; OS; overall survival; PVT; portal vein thrombosis; TTP; time to progression; TTT; time to toxicity; 90Y; ytt
Keywords: AC; activity concentration; BSA; body surface area; IQR; interquartile range; LLS; liver-lung shunt; LV; liver volume; RE; radioembolization; RF; reduction factor; 99mTc-MAA; technetium-99m macroaggregated albumin; 90Y; yttrium-90;
Keywords: GM; geometic mean; HCC; hepatocellular carcinoma; HV; hepatic vein; LSF; lung shunt fraction; MAA; macroaggregated albumin; OR; odds ratio; PV; portal vein; 99mTc; technetium-99m; 90Y; yttrium-90;
Keywords: ID; inner diameter; NRC; Nuclear Regulatory Commission; RE; radioembolization; 90Y; yttrium-90;
Keywords: HCC; hepatocellular carcinoma; HPSF; hepatopulmonary shunt fraction; HVTT; hepatic vein tumor thrombus; MIRD; medical internal radiation dose; PVA; polyvinyl alcohol; PVTT; portal vein tumor thrombus; RE; radioembolization; RP; radiation pneumonitis; 99mT
Keywords: HA; hepatic arterial; SIRT; selective internal radiation therapy; 99mTc-MAA; technetium-99m albumin aggregated; 90Y; yttrium-90;
Keywords: AFP; α-fetoprotein; AUC; area under the curve; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; IL; interleukin; mRECIST; modified Response Evaluation Criteria In Solid Tumors; NLR; neutrophil-to-lymphocyte ratio; RE; radioembolization
Keywords: DSA; digital subtraction angiography; LSF; lung shunt fraction; MIRD; medical internal radiation dose; SPECT; single photon emission computed tomography; 99mTc-MAA; technetium-99m macroaggregated albumin; 90Y; yttrium-90;
Keywords: CI; confidence interval; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; PVT; portal vein thrombosis; TIPS; transjugular intrahepatic portosystemic shunt; TTP; time to progression; 90Y; yttrium-90;
Keywords: BSA; body surface area; CEA; carcinoembryonic antigen; DWL; whole-liver absorbed dose; mCRC; metastatic colorectal carcinoma; RECIST; Response Evaluation Criteria in Solid Tumors; REILD; radioembolization-induced liver disease; SPECT; single photon emissi
Keywords: BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; 90Y; yttrium-90;
Keywords: AFP; α-fetoprotein; AIC; Akaike information criterion; BCLC; Barcelona Clinic Liver Cancer; C-index; concordance index; CLIP; Cancer of the Liver Italian Program; CTP; Child-Turcotte-Pugh; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular car
Keywords: aFGF; acidic fibroblast growth factor; Ang-2; angiopoietin-2; bFGF; basic fibroblast growth factor; Conc; concentration; FGFR; fibroblast growth factor receptor; G-CSF; granulocyte colony-stimulating factor; GM-CSF; granulocyte-macrophage colony-stimulati
Keywords: BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; LSF; lung shunt fraction; PVT; portal vein thrombosis; ROI; region of interest; SPECT; single photon emission computed tomography; 99mTc-MAA; technetium-99m macroaggregated albumin; TD; t
Patient Radiation Exposure in Transradial versus Transfemoral Yttrium-90 Radioembolization: A Retrospective Propensity Score-Matched Analysis
Keywords: AK; air kerma; DAP; dose-area product; FT; fluoroscopy time; PRE; patient radiation exposure; TARE; transarterial yttrium-90 radioembolization; TFA; transfemoral access; TRA; transradial access; 90Y; yttrium-90;
Long-Term Toxicity after Transarterial Radioembolization with Yttrium-90 Using Resin Microspheres for Neuroendocrine Tumor Liver Metastases
Keywords: ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; HR; hazard ratio; NET; neuroendocrine tumor; TARE; transarterial radioembolization; 90Y; yttrium-90;
Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study
Keywords: CA; cancer antigen; CI; confidence interval; ECOG; Eastern Cooperative Oncology Group; ICC; intrahepatic cholangiocarcinoma; INR; international normalized ratio; MELD; Model for End-Stage Liver Disease; OS; overall survival; RECIST; Response Evaluation Cr
90Y radioembolization dosimetry using a simple semi-quantitative method in intrahepatic cholangiocarcinoma: Glass versus resin microspheres
Keywords: Intrahepatic cholangiocarcinoma; 90Y; Radioembolization; Dosimetry; Glass; Resin;
Formulation and purification of therapeutic dose of 90Y-labeled peptides: Some interesting radiochemistry aspects
Keywords: Neuroendocrine tumors; 90Y; DOTA-TATE; Therapeutic dose; 90Sr/90Y generator; Radionuclidic purity;
Long-Term Hepatotoxicity of Yttrium-90 Radioembolization as Treatment of Metastatic Neuroendocrine Tumor to the Liver
Keywords: mNET; metastatic neuroendocrine tumor; 90Y; yttrium-90;
Tumor Dose Response in Yttrium-90 Resin Microsphere Embolization for Neuroendocrine Liver Metastases: A Tumor-Specific Analysis with Dose Estimation Using SPECT-CT
Keywords: CR; complete response; HCC; hepatocellular carcinoma; LSF; lung shunt fraction; mRECIST; Modified Response Evaluation Criteria in Solid Tumors; NET; neuroendocrine tumor; PD; progressive disease; PR; partial response; SD; stable disease; SPECT; single pho
Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT
Keywords: AD; absorbed dose; CI; confidence interval; HCC; hepatocellular carcinoma; MAA; macroaggregated albumin; mRECIST; modified RECIST; PET; positron emission tomography; RDC; reproducibility coefficient; RE; radioembolization; RECIST; Response Evaluation Crit
Time optimization of 90Sr measurements: Sequential measurement of multiple samples during ingrowth of 90Y
Keywords: 90Sr; 90Y; Optimization; Sequential measurement; Multiple samples;
Radioembolization following Liver Resection: Safety and Dosing Considerations
Keywords: BSA; body surface area; CI; confidence interval; RE; radioembolization; REILD; radioembolization-induced liver disease; 90Y; yttrium-90;
Yttrium-90 Radioembolization as a Salvage Treatment following Chemoembolization for Hepatocellular Carcinoma
Keywords: BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; TARE; transarterial radioembolization; 90Y; yttrium-90;
Intravoxel Incoherent Motion Diffusion-Weighted MR Imaging for Prediction of Early Arterial Blood Flow Stasis in Radioembolization of Breast Cancer Liver Metastases
Keywords: ADC; apparent diffusion coefficient; Dâ²; estimated true diffusion coefficient; DWI; diffusion-weighted imaging; fâ²; estimated perfusion fraction; IVIM; intravoxel incoherent motion; LdBM; liver dominant breast metastases; ROC; receiver operating chara
Bariatric Radioembolization: A Pilot Study on Technical Feasibility and Safety in a Porcine Model
Keywords: BAE; bariatric arterial embolization; EBRT; external-beam radiation therapy; GI; gastrointestinal; H&E; hematoxylin-eosin; HPF; high-power field; LGA; left gastric artery; MAA; macroaggregated albumin; NTE; nontarget embolization; TARE; transarterial radi
Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability
Keywords: CI; combination index; HCC; hepatocellular carcinoma; ICC; intrahepatic cholangiocarcinoma; MTT; tetrazolium dye reduction; SIRT; selective internal radiation therapy; 90Y; yttrium-90;
Dosimetry of a 90Y-hydroxide liquid brachytherapy treatment approach to canine osteosarcoma using PET/CT
Keywords: Radionuclide therapy; Brachytherapy; PET-CT; 90Y; Osteosarcoma; Canine; Dog; Sarcoma Tumor; Bone hydroxide;
Radiochemistry, pre-clinical studies and first clinical investigation of 90Y-labeled hydroxyapatite (HA) particles prepared utilizing 90Y produced by (n,γ) route
Keywords: Radiation synovectomy (RSV); 90Y; (n,γ) production; Hydroxyapatite (HA); Kit formulation
KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases
Keywords: CEA; carcinoembryonic antigen; CI; confidence interval; CRC; colorectal cancer; EGFR; epidermal growth factor receptor; KRAS; Kirsten rat sarcoma viral oncogene homolog; OS; overall survival; wt; wild-type; 90Y; yttrium-90;
Intraprocedural Yttrium-90 Positron Emission Tomography/CT for Treatment Optimization of Yttrium-90 Radioembolization
Keywords: BSA; body surface area; 18FDG; fluorine 18-labeled deoxyglucose; HCC; hepatocellular carcinoma; 99mTc MAA; technetium-99m macroaggregated albumin; T/N; tumor-to-normal uptake; TTR; tumoricidal target ratio; 90Y; yttrium-90;
Quantitative Dosimetry for Yttrium-90 Radionuclide Therapy: Tumor Dose Predicts Fluorodeoxyglucose Positron Emission Tomography Response in Hepatic Metastatic Melanoma
Keywords: CC; correlation coefficient; DVH; dose-volume histogram; EORTC; European Organization for Research and Treatment of Cancer; HCC; hepatocellular carcinoma; PMR; partial metabolic response; SD; standard deviation; SUVmax; maximum standardized uptake value;
Gold nanorod-mediated hyperthermia enhances the efficacy of HPMA copolymer-90Y conjugates in treatment of prostate tumors
Keywords: 111In; 90Y; SPECT imaging; HPMA; Hyperthermia; Radiotherapy;
Microsphere Localization and Dose Quantification Using Positron Emission Tomography/CT following Hepatic Intraarterial Radioembolization with Yttrium-90 in Patients with Advanced Hepatocellular Carcinoma
Keywords: HCC; hepatocellular carcinoma; MDC; minimum detectable concentration; 99mTc-MAA; technetium-99m-labeled macroaggregated albumin; 90Y; yttrium-90;